Oruka Therapeutics, Inc. ORKA Shares (Diluted)
Discontinued — last reported Q2 '25
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s shares (diluted)?
- Oruka Therapeutics, Inc. (ORKA) reported shares (diluted) of 42.1M in Q2 2025.
- How has Oruka Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Oruka Therapeutics, Inc.'s shares (diluted) increased by 1216.3% year-over-year, from 3.2M to 42.1M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s shares (diluted)?
- Over 3 years (2021 to 2024), Oruka Therapeutics, Inc.'s shares (diluted) has grown at a -11.5% compound annual growth rate (CAGR), from 55.1M to 38.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.